Association between polymorphisms of eNOS and GPx-1 genes, activity of free-radical processes and in-stent restenosis

Molecular and Cellular Biochemistry

Volumn 370, Issue 1-2, 2012, Pages 241-249

  Shuvalova, Yu A ^a   Kaminnyi, A I ^a   Meshkov, A N ^b   Shirokov, R O ^c   Samko, A N ^c  

^a Russ Cardiol Res and Prod Complex of the Russ Fed Ministry of Health and Social Development   (Russian Federation)

^b NATIONAL MEDICAL RESEARCH CENTER FOR THERAPY AND PREVENTIVE MEDICINE   (Russian Federation)

^c INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Antioxidant enzymes; Genetic risk factors; GPx 1 gene polymorphism; In stent restenosis; Lipid peroxidation

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CATALASE; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FREE RADICAL; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE TRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ADULT; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BLOOD SAMPLING; CAROTID ARTERY STENTING; ENZYME ACTIVITY; ERYTHROCYTE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; ERYTHROCYTES; FREE RADICALS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDES; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; STENTS;

EID: 84867335008     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1419-3     Document Type: Article

References (36)

1. Spertus JA, Nerella R, Kettlekamp R, House J, Marso S, Borkon MA, Rumsfeld JS (2005) Risk of restenosis and health status outcomes for patients undergoing percutaneous coronary intervention versus coronary artery bypass graft surgery. Circulation 111:768-773. doi: 10.1161/01.CIR.0000155242.70417.60
2. Kastrati A, Koch W, Gawaz M, Mehilli J, Böttiger C, Schömig K, von Beckerath N, Schömig A (2000) PLA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement. J Am Coll Cardiol 36:84-89
3. Kastrati A, Koch W, Berger PB, Mehilli J, Stephenson K, Neumann F-J, von Beckerath N, Böttiger C, Duff GW, Schömig A (2000) Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol 36:2168-2173
4. Wijpkema JS, Van Haelst PL, Monraats PS, Bruinenberg M, Zwinderman AH, Zijlstra F, van der Steege G, de Winter RJ, Doevendans PA, Waltenberger J, Jukema JW, Tio RA (2006) Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or hemeoxygenase-1. Pharmacogenet Genomics 16:331-337
5. Galluccio E, Piatti PM, Citterio L, Lucotti PCG, Setola E, Cassina L, Oldani M, Zavaroni I, Bosi E, Colombo A, Alfieri O, Casari G, Reaven GM, Monti LD (2008) Hyperinsulinemia and impaired leptin: adiponectin ratio associate with endothelial nitric oxide synthase polymorphisms in patients with in-stent restenosis. Am J Physiol Endocrinol Metab 294:E978-E986. doi: 10.1152/ajpendo.00003.2008
6. Azevedo LC, Pedro MA, Souza LC, de Souza HP, Janiszewski M, da Luz PL, Laurindo FRM (2000) Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc Res 47:436-445. doi: 10.1016/S0008-6363(00)00091-2
7. Hoffmann R, Mintz GS (2000) Coronary in-stent restenosispredictors, treatment and prevention. Eur Heart J 21:1739-1749. doi: 10.1053/euhj.2000.2153
8. Iuliano L, Colavita AR, Leo R, Pratico D, Violi F (1997) Oxygen free radicals and platelet activation. Free Radic Biol Med 22:999-1006
9. Fortuno A, San Jose G, Moreno MU, Díez J, Zalba G (2005) Oxidative stress and vascular remodelling. Exp Physiol 90:457-462. doi: 10.1113/expphysiol.2005.030098
10. Zhou XF, Cui J, De Stefano Al, Chazaro I, Farrer LA, Manolis AJ, Gavras H, Baldwin CT (2005) Polymorphisms in the promoter region of catalase gene and essential hypertension. Dis Markers 21:3-7
11. Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, Schmitt D, Fu X, Shao M, Brennan DM, Ellis SG, Brennan M-L, Allayee H, Lusis AJ, Hazen SL (2008) Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 299:1265-1276. doi: 10.1001/jama.299.11.1265
12. Van Himbergen TM, Roest M, Graaf J, Jansen EHJM, Hattori H, Kastelein JJP, Voorbij HAM, Stalenhoef AFH, van Tits LJH (2005) Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia. J Lipid Res 46:445-451. doi: 10.1194/jlr.M400052-JLR200
13. Colombo MG, Paradossi U, Andreassi MG, Botto N, Manfredi S, Masetti S, Biagini A, Clerico A (2003) Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem 49:389-395. doi: 10.1373/49.3.389
14. Schnabel R, Lackner KJ, Rupprecht HJ, Espinola-Klein C, Torzewski M, Lubos E, Bickel C, Cambien F, Tiret L, Münzel T, Blankenberg S (2005) Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction. J Am Coll Cardiol 45:1631-1637. doi: 10.1016/j.jacc.2005.02.053
15. Nemoto M, Nishimura R, Sasaki T, Hiki Y, Miyashita Y, Nishioka M, Fujimoto K, Sakuma T, Ohashi T, Fukuda K, Eto Y, Tajima N (2007) Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes: a case control study with multi-slice computed tomography. Cardiovasc Diabetol 6:23-27
16. Amplatz K, Formanek G, Stranger P, Wilson W (1967) Mechanics of selective coronary artery catheterization via femoral approach. Radiology 89:1040-1047. doi: 10.1148/89.6.1040
17. Judkins MP (1967) Selective coronary arteriography. Part I. A percutaneous transfemoral technic. Radiology 89:815-824. doi: 10.1148/89.5.815
18. Tertov VV, Kaplun VV, Dvoryantsev SN, Orekhov AN (1995) Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo. Biochem Biophys Res Commun 214:608-613
19. Lankin VZ, Lisina MO, Arzamastseva NE, Konovalova GG, Nedosugova LV, Kaminnyi AI, Tikhaze AK, Ageev AK, Kukharchuk VV, Belenkov YN (2005) Oxidative stress in atherosclerosis and diabetes. Bull Exp Biol Med 140:41-43
20. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP (1994) Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 220:403-409
21. Boldyrev AA, Yuneva MO, Sorokina EV, Kramarenko GG, Fedorova TN, Konovalova GG, Lankin VZ (2001) Antioxidant systems in tissues of senescence accelerated mice. Biochemistry (Mosc) 66:1157-1163
22. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
23. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57:289-300
24. Lowe HC, Oesterle SN, Khachigian LM (2002) Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 39:183-193
25. Inouye M, Mio T, Sumino K (1999) Link between glycation and lipooxidation in red blood cells in diabetes. Clin Chim Acta 285:35-44
26. Ravn-Haren G, Olsen A, Tjonneland A, Dragsted LO, Nexo BA, Wallin H, Overvad K, Raaschou-Nielsen O, Vogel U (2006) Association between GPx-1 Pro198Leu polymorphism, erythrocyte GPx activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 27:820-825. doi: 10.1093/carcin/bgi267
27. Hamanishi T, Fyryta H, Kato H, Doi A, Tamai M, Shimomura H, Sakagashira S, Nishi M, Sasaki H, Sanke T, Nanjo K (2004) Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intimamedia thickness of carotid arteries and risk of macrovascular disease in Japanese type 2 diabetic patients. Diabetes 53:2455-2460. doi: 10.2337/diabetes.53.9.2455
28. Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide and peroxynitrite: the good, the bad and ugly. Am J Physiol 5:1424-1437
29. Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner G, Tiret L, Smieja M, Cambien F, Meyer J, Lackner KJ, AtheroGene Investigators (2003) Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 349:1605-1613
30. Suzuki T, Okumura K, Sone T, Kosokabe T, Tsuboi H, Kondo J, Mukawa H, Kamiya H, Tomida T, Imai H, Matsui H, Hayakawa T (2002) The Glu298Asp polymorphism in endothelial nitric oxide synthase gene is associated with coronary in-stent restenosis. Int J Cardiol 86:71-76
31. Gomma AH, Elrayess MA, Knight CJ, Hawe E, Fox KM, Humphries SE (2002) The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphism are associated with coronary in-stent restenosis. Eur Heart J 23:1955-1962. doi: 10.1053/euhj.2002.3400
32. Garg UC, Hassid A (1989) Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774-1777. doi: 10.1172/JCI114081
33. Griendling KK, Fitzgerald GF (2003) Oxidative stress and cardiovascular injury part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108:1912-1916. doi: 10.1161/01.CIR.0000093660.86242.BB
34. Jain SK, Palmer M (1997) The effects of oxygen radicals metabolites and vitamin E on glycosylation of proteins. Free Radic Biol Med 22:593-596
35. Tesauro M, Tompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J (2000) Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary disease: cleavage of proteins with aspartate vs. glutamate at position 298. PNAS 97:2832-2835. doi: 10.1073/pnas.97.6.2832
36. Khalkhai-Ellis Z, Hendrix MJ (2003) Nitric oxide regulation of maspin expression in normal mammary epithelial and breast cancer cells. Am J Pathol 162:1411-1417